|
EQS-Ad-hoc: Redcare Pharmacy N.V. / Key word(s): Forecast / Full year
Redcare Pharmacy N.V. announces guidance for 2026.
03-March-2026 / 22:32 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group.
The issuer is solely responsible for the content of this announcement.
Redcare Pharmacy N.V. announces guidance for 2026.
Sevenum, the Netherlands, March 3, 2026. The Management Board of Redcare Pharmacy N.V. has determined its guidance for 2026:
- Total revenue growth of 13% to 15%.
- Rx revenue in Germany in excess of EUR 670 million.
- Non-Rx revenue growth of 8% to 10%.
- Adjusted EBITDA margin of at least 2.5%.
Contact:
rikutis consulting
Thomas Schnorrenberg
Cel: +49 151 46 53 13 17
E-Mail: presse@shop-apotheke.com
End of Inside Information
03-March-2026 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
View original content: EQS News
|
